Surgical Endoscopy

, Volume 7, Issue 6, pp 472–478

Portal hypertension management

  • J. Terblanche
The Gerald Marks Lecture

Summary

Injection sclerotherapy is the mainstay of treatment for acute variceal bleeding and for long-term management after a variceal bleed. In those few patients in whom sclerotherapy fails to control acute bleeding, either a surgical shunt or a simple esophageal transection is recommended. A surgical shunt or a more extensive esophagogastric evascularization and transection operation is advocated for the failures of long-term sclerotherapy management. The role of pharmacological agents in acute variceal bleed management remains in question, and the use of propranolol in long-term management, either as an alternative to sclerotherapy or in combination with sclerotherapy, is controversial. The definitive roles of the newly described variceal banding and transjugular intrahepatic portosystemic shunts (TIPS) procedures have yet to be established. All patients presenting with end-stage liver disease and esophageal variceal bleeding should be evaluated for a liver transplant, although few will qualify. A possible future transplant should be kept in mind when emergency treatment is planned. Any form of prophylactic therapy for patients with esophageal varices that have not yet bled will remain unjustified until those patients at high risk of a first variceal bleed can be identified. The gastric mucosal lesion, portal hypertensive gastropathy, has been underdiagnosed in the past. Although bleeding does occur, it is seldom a major clinical problem. When necessary, bleeding can be controlled by propranolol or a surgical shunt.

Key words

Portal hypertension Esophageal varices Sclerotherapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adam R, Diamond T, Bismuth H (1992) Partial portacaval shunt: renaissance of an old concept. Surgery 111: 610–616Google Scholar
  2. 2.
    Anonymous (1991) Portal hypertensive gastropathy. Lancet 338: 1045–1046Google Scholar
  3. 3.
    Anonymous(1992) Bleeding oesophageal varices: IST, EVL, or TIPs. Lancet 340: 515–516Google Scholar
  4. 4.
    Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M (1981) Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27: 213–218Google Scholar
  5. 5.
    Bornman PC, Terblanche J, Kahn D, Jonker MA, Kirsch RE (1986) Limitations of multiple injection sclerotherapy sessions for acute variceal bleeding. S Afr Med J 70: 34–36Google Scholar
  6. 6.
    Burroughs AK, Hamilton G, Phillips A, Mezzanotte G, McIntyre N, Hobbs KEF (1989) A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 321: 857–862Google Scholar
  7. 7.
    Burroughs AK, McCormick PA, Hughes MD, Sprengers D, D'Heygere F, McIntyre N (1990) Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology 99: 1388–1395Google Scholar
  8. 8.
    Conn HO (1993) Transjugular intrahepatic portal-systemic shunts: The state of the art. Hepatology 17: 148–158Google Scholar
  9. 9.
    Dasarathy S, Dwivedi M, Bhargava DK, Sundaram KR, Ramachandran K (1992) A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child Class B and C) cirrhotic patients. Hepatology 16: 89–94Google Scholar
  10. 10.
    De Franchis R, Primignani M, Arcidiacono PG, Rizzi PM, Vitagliano P, Vazzoler MC, Arcidiacono R, Rossi A, Zambelli A, Cosentino F, Caletti G, Brunati S, Battaglia G, Gerunda G (1991) Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria. A multicenter randomized controlled trial. Gastroenterology 101: 1087–1093Google Scholar
  11. 11.
    Dudley FJ (1992) Somatostatin and portal hypertensive bleeding: A safe therapeutic alternative? Gastroenterology 103: 1973–1977Google Scholar
  12. 12.
    Fleig WE, Stange EF, Hunecke R, Schonborn W, Hurler U, Rainer K, Gaus W, Ditschuneit H (1987) Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: Prospective randomized comparison of propranolol and sclerotherapy. Hepatology 7: 355–361Google Scholar
  13. 13.
    Gimson A, Polson R, Westaby D, Williams R (1990) Omeprazole in the management of intractable esophaeal ulceration following injection sclerotherapy. Gastroenterology 99: 1829–1831Google Scholar
  14. 14.
    Haskal ZJ, Ring EJ, La Berge JM, Peltzer MY Radosevich PM, Doherty MM, Gordon RL (1992) Role of parallel transjugular intrahepatic portosystemic shunts in patients with persistent portal hypertension. Radiology 185: 813–817Google Scholar
  15. 15.
    Hayes PC, Davis JM, Lewis JA, Bouchier IAD (1990) Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 336: 153–156Google Scholar
  16. 16.
    Henderson JM, Gilmore GT, Hooks MA, Galloway JR, Dodson TF, Hood MM, Kutner MH, Boyer TD (1992) Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg 216: 248–255Google Scholar
  17. 17.
    Hwang S-J, Lin H-C, Chang C-F, Lu F-Y, Lee C-W, Hsia H-C, Wang S-S, Lee S-D, Tsai Y-T, Lo K-J (1992) A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 16: 320–325Google Scholar
  18. 18.
    Infante-Rivard C, Esnaola S, Villeneuve JP (1989) Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: A meta-analysis. Gastroenterology 96: 1087–1092Google Scholar
  19. 19.
    Inokuchi K and Cooperative Study Group of Portal Hypertension of Japan (1990) Improved survival after prophylactic portal nondecompression surgery for esophageal varices: A randomized clinical trial. Hepatology 12: 1–6Google Scholar
  20. 20.
    Iwatsuki S, Starzl TE, Todo S, Gordon RD, Tzakis AG, Marsh JW, Makowka L, Koneru B, Stieber A, Klintmalm G, Husberg B, van Thiel D (1988) Liver transplantation in the treatment of bleeding esophageal varices. Surgery 104: 697–705Google Scholar
  21. 21.
    Jenkins SA, Shields R, Jaser N, Ellenbogen S, Makin C, Naylor E, Newtead M, Baxter JN (1991) The management of gastrointestinal haemorrhage by somatostatin after apparently successful endoscopic injection sclerotherapy for bleeding oesophageal varices. J Hepatol 12: 296–301Google Scholar
  22. 22.
    Jensen LS, Krarup N (1989) Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. Scand J Gastroenterol 24: 339–345Google Scholar
  23. 23.
    Kahn D, Bornman PC, Terblanche J (1989) A 10-year prospective evaluation of balloon tube tamponade and emergency injection sclerotherapy for actively bleeding esophageal varices. HPB Surg 1: 207–219Google Scholar
  24. 24.
    Kahn D, Jones B, Bornman PC, Terblanche J (1989) Incidence and management of complications after injection sclerotherapy: a 10-year prospective evaluation. Surgery 105: 160–165Google Scholar
  25. 25.
    Kaye GL, McCormick A, Siringo S, Hobbs KEF, McIntyre N, Burroughs AK (1992) Bleeding from staple line erosion after esophageal transection: Effect of omeprazole. Hepatology 15: 1031–1035Google Scholar
  26. 26.
    Kitano S, Koyanagi N, Iso Y, Higashi H, Sugimachi K (1987) Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 7: 810–815Google Scholar
  27. 27.
    Kitano S, Iso Y, Hashizume M, Yamaga H, Koyanagi N, Wada H, Iwanaga T, Ohta M, Sugimachi K (1992) Sclerotherapy vs. esophageal transection vs. distal splenorenal shunt for the clinical management of esophageal varices in patients with Child Class A and B liver function: A prospective randomized trial. Hepatology 15: 63–68Google Scholar
  28. 28.
    Kleber G, Sauerbruch T, Fischer G, Geigenberger G, Paumgartner G (1991) Reduction of transmural oesophageal variceal pressure by metoclopramide. J Hepatol 12: 362–366Google Scholar
  29. 29.
    La Berge JM, Ring EJ, Lake JR, Ferrell LD, Doherty MM, Gordon RL, Roberts JP, Peltzer MY, Ascher N (1992) Transjugular intrahepatic portosystemic shunts: Preliminary results in 25 patients. J Vasc Surg 16: 258–267Google Scholar
  30. 30.
    Marbet UA, Straumann A, Gyr KE, Beglinger C, Schaub N, Vogtlin J, Loosli J, Kiowski W, Ritz R, Stalder GA (1988) Reduction in early recurrence of variceal bleeding by propranolol. Scand J Gastroenterol 23: 369–374Google Scholar
  31. 31.
    McCormick PA, Kaye GL, Greenslade L, Cardin F, Hobbs KEF, McIntyre N, Burroughs AK (1992) Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy. Hepatology 15: 403–406Google Scholar
  32. 32.
    Orloff MJ, Orloff MS, Rambotti M. Girard V (1992) Is portal-systemic shunt worthwhile in Child's Class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann Surg 216: 256–268Google Scholar
  33. 33.
    Pagliaro L, D'Amico G, Sorensen TIA, Lebrec D, Burroughs AK, Morabito A, Tine F, Politi F, Traina M (1992) Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of non-surgical treatment. Ann Intern Med 117: 59–70Google Scholar
  34. 34.
    Perez-Ayuso RM, Pique JM, Bosch J, Panes J, Gonzalez A, Perez R, Rigau J, Quintero E, Valderrama R, Viver J, Esteban R, Rodrigo L, Bordas JM, Rodes J (1991) Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 337: 1431–1434Google Scholar
  35. 35.
    Reveille RM, Goff JS, Stiegmann GV, Stauffer JT (1991) Combination endoscopic variceal ligation (EVL) and low-volume endoscopic sclerotherapy (ES) for bleeding esophageal varices: a faster route to variceal eradication? Gastrointest Endosc 37: 243 (Abstr)Google Scholar
  36. 36.
    Rikkers LF, Jin G, Burnett DA, Bucki KN, Cormier RA (1993) Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: Late results of a randomized trial. Amer J Surg 165: 27–33Google Scholar
  37. 37.
    Saeed ZA, Michaletz PA, Winchester CB, Woods KL, Dixon WB, Heiser MC, Gentry KR, Ramirez FC (1990) Endoscopic variceal ligation in patients who have failed endoscopic sclerotherapy. Gastrointest Endosc 36: 572–574Google Scholar
  38. 38.
    Sarfeh IJ, Rypins EB, Mason GR (1986) A systematic appraisal of portacaval H-grafts diameters. Clinical and hemodynamic perspectives. Ann Surg 204: 356–363Google Scholar
  39. 39.
    Shields R, Jenkins SA, Baxter JN (1992) A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol 16: 128–137Google Scholar
  40. 40.
    Spina GP, Henderson JM, Rikkers LF, Teres J, Burroughs AK, Conn HO, Pagliaro L, Santambrogio R (1992) Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of four randomized clinical trials. J Hepatol 16: 338–345Google Scholar
  41. 41.
    Stiegmann GV, Goff JS (1988) Endoscopic esophageal varix ligation (EDL): preliminary clinical experience. Gastrointest Endosc 34: 105–108Google Scholar
  42. 42.
    Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, Reveille RM, Sun JH, Lowenstein SR (1992) Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326: 1527–1532Google Scholar
  43. 43.
    Sugiura M, Futagawa S (1984) Results of six hundred and thirty-six esophageal transections with paraesophagogastric devascularization in the treatment of esophageal varices. J Vasc Surg 1: 254–260Google Scholar
  44. 44.
    Taranto D, Suozzo R, de Sio I, Romano M, Caporaso N, Blanco CDV, Coltorti M (1990) Effect of metoclopramide on transmural oesophageal variceal pressure and portal blood flow in cirrhotic patients. Digestion 47: 56–60Google Scholar
  45. 45.
    Terblanche J, Kahn D, Campbell JAH, Bornman PC, Jonker MAT, Wright J, Kirsch RE (1983) Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet 2: 1328–1332Google Scholar
  46. 46.
    Terblanche J (1989) The surgeon's role in the management of portal hypertension. Ann Surg 209: 381–395Google Scholar
  47. 47.
    Terblanche J, Burroughs AK, Hobbs KEF (1989) Controversies in the management of bleeding esophageal varices. N Engl J Med 320: 1393–1398; 1469–1475Google Scholar
  48. 48.
    Terblanche J, Kahn D, Bornman PC (1989) Long-term injection sclerotherapy treatment for esophageal varices: a 10-year prospective evaluation. Ann Surg 210: 725–731Google Scholar
  49. 49.
    Terblanche J (1990) Has sclerotherapy altered the management of patients with variceal bleeding? Amer J Surg 160: 37–42Google Scholar
  50. 50.
    Terblanche J, Krige JEJ, Bornman PC (1992) The treatment of esophageal varices. Annu Rev Med 43: 69–82Google Scholar
  51. 51.
    The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 319: 983–989Google Scholar
  52. 52.
    The Prova Study Group (1991) Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicentre trial. Hepatology 14: 1016–1024Google Scholar
  53. 53.
    The Veterans Affairs Cooperative Variceal Sclerotherapy Group (1991) Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. N Engl J Med 324: 1779–1784Google Scholar
  54. 54.
    Triger DR, Johnson AG, Brazier JE, Johnston GW, Spencer EFA, McKee R, Anderson JR, Carter DC (1992) A prospective trial of endoscopic sclerotherapy v oesophageal transection and gastric devascularization in the long-term management of bleeding oesophageal varices. GUT 33: 1553–1558Google Scholar
  55. 55.
    Triger DR, Smart HL, Hosking SW, Johnson AG (1991) Prophylactic sclerotherapy for esophageal varices: Long-term results of a single-center trial. Hepatology 13: 117–123Google Scholar
  56. 56.
    Vinel JP, Lamouliatte H, Cales P, Combis J-M, Roux D, Desmorat H, Pradere B, Barjonnet G, Quinton A, Pascal J-P (1992) Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology 102: 1760–1763Google Scholar
  57. 57.
    Warren WD, Henderson JM, Millikan WJ, Galambos JT, Brooks WS, Riepe SP, Salam AA, Kutner MH (1986) Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding: preliminary report of a prospective, randomized trial. Ann Surg 203: 454–462Google Scholar

Copyright information

© Springer-Verlag New York Inc 1993

Authors and Affiliations

  • J. Terblanche
    • 1
    • 2
    • 3
  1. 1.Department of SurgeryUniversity of Cape Town, and Groote Schuur HospitalCape TownSouth Africa
  2. 2.Medical Research Council Liver Research CentreUniversity of Cape TownSouth Africa
  3. 3.Centre de Chirurgie Digestive et Unite de TransplantationCentre Hospitalier Regional et Universitaire de Rennes, PontchaillouRennes CedexFrance

Personalised recommendations